Based on attendance or presentation at prior events, here is a list of potential events (mostly science meetings, some investor conferences) for Resverlogix in the year of the big news. This is just a draft/preliminary list and there is no guarantee that Resverlogix will present at the events listed below. With the exception of ACC in March and Vascular Discovery in May, note the dearth of science meetings January to May. Did I miss any? If so, let me know!

Biotech Showcase January 7-9, 2018; San Francisco, CA

BIO CEO & Investor Conference February 11-12, 2019; New York, NY

American College Cardiology (ACC) March 16-18, 2019; New Orleans, LA 

BIO-Europe Spring March 25-27, 2018; Vienna, Austria

Vascular Discovery: From Genes to Medicine (Formerly ATVB:PVD): May 14-16, 2019; Boston, MA

European Renal Association – European Dialysis and Transplant Association (ERA-EDTA): June 13-16, 2019; Budapest, Hungary

BIO-International June 3-6, 2019; Philadelphia, PA

American Diabetes Association (ADA) June 7-11, 2019; San Francisco, CA

Alzheimer's Association International Conference (AAIC) July 14-18, 2019; Los Angeles, CA

European Society of Cardiology (ESC) August 31 to Sept 4, 2019; Paris, France

Clinical Trials on Alzheimer's Disease/Asia  (CTAD Asia) September 13-14, 2019; Beijing, China

European Association for the Study of Diabetes (EASD): Sept 16-20, 2019; Barcelona, Spain

American Society for Nephrology (ASN) Kidney Week Nov 5-10, 2018; Washington, D.C.

BIO-Europe Nov 11-13, 2019

American Heart Association (AHA) November 16-18, 2019; Philadelphia, PA

Clinical Trials on Alzheimer's Disease (CTAD) December 4-7, 2019; San Diego, CA